Patient self-control and self-dosing of oral anticoagulant treatment with vitamin K antagonists;Zelfcontrole en -dosering van orale antistollingsbehandeling met vitamine-K-antagonisten

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 48, 2001, Pages 2313-2317

  Levi, M ^a   De Bruin, T A ^a   Van Der Meer, F J M ^a   Cromheecke, M E ^a   De Mol, B A J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

ANTICOAGULATION; BLOOD SAMPLING; DOSE CALCULATION; DRUG EFFECT; DRUG EFFICACY; INTERNATIONAL STANDARD UNIT; MACHINE; NETHERLANDS; RELIABILITY; REVIEW; SELF CONTROL; THROMBOSIS; TRAVEL;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; NETHERLANDS; SELF ADMINISTRATION; SELF CARE; THROMBOLYTIC THERAPY; VITAMIN K;

EID: 0035576054     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Oral anticoagulant drugs
2. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
3. Determinants of the response to oral anticoagulant drugs in man
4. Optimal oral anticoagulant therapy in patients with mechanical heart valves
5. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
6. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: Laboratory monitoring of oral anticoagulant therapy
7. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: A comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants
8. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction
9. Advances in the monitoring of oral anticoagulation: Point-of-care testing, patient self-monitoring, and patient self-management
10. Empowering patients to monitor and manage oral anticoagulation therapy
11. Multicenter evaluation of a new capillary blood prothrombin time monitoring system
12. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study
13. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy
14. Prevention of major bleeding in older patients treated with warfarin: Results of a randomized trial
15. Long-term patient self-management of oral anticoagulation
16. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy
17. Self management of oral anticoagulant therapy after heart valve replacement
18. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial
19. INR self-management following mechanical heart valve replacement
20. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomised cross-over comparison
21. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease
22. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor
23. Meta-analysis of diabetes patient education research: Variations in intervention effects across studies
24. Effectiveness of health education and health promotion: Meta-analyses of effect studies and determinants of effectiveness
25. Cost-effectiveness of selfmanaged anticoagulant therapy in Germany